These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 28007541)
1. Calcineurin signaling in the heart: The importance of time and place. Parra V; Rothermel BA J Mol Cell Cardiol; 2017 Feb; 103():121-136. PubMed ID: 28007541 [TBL] [Abstract][Full Text] [Related]
2. Calcineurin and its regulator, RCAN1, confer time-of-day changes in susceptibility of the heart to ischemia/reperfusion. Rotter D; Grinsfelder DB; Parra V; Pedrozo Z; Singh S; Sachan N; Rothermel BA J Mol Cell Cardiol; 2014 Sep; 74():103-11. PubMed ID: 24838101 [TBL] [Abstract][Full Text] [Related]
3. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416 [TBL] [Abstract][Full Text] [Related]
4. Calcineurin in the heart: New horizons for an old friend. Chaklader M; Rothermel BA Cell Signal; 2021 Nov; 87():110134. PubMed ID: 34454008 [TBL] [Abstract][Full Text] [Related]
5. Sustained hemodynamic stress disrupts normal circadian rhythms in calcineurin-dependent signaling and protein phosphorylation in the heart. Sachan N; Dey A; Rotter D; Grinsfelder DB; Battiprolu PK; Sikder D; Copeland V; Oh M; Bush E; Shelton JM; Bibb JA; Hill JA; Rothermel BA Circ Res; 2011 Feb; 108(4):437-45. PubMed ID: 21233454 [TBL] [Abstract][Full Text] [Related]
6. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927 [TBL] [Abstract][Full Text] [Related]
7. Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes. Lim HW; New L; Han J; Molkentin JD J Biol Chem; 2001 May; 276(19):15913-9. PubMed ID: 11279073 [TBL] [Abstract][Full Text] [Related]
8. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855 [TBL] [Abstract][Full Text] [Related]
17. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways. Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128 [TBL] [Abstract][Full Text] [Related]